周四盘中，法国制药巨头赛诺菲（SNY）股价大幅下跌9.02%，延续了盘前的跌势。这一显著跌幅主要源于公司发布的第二季度财报未能完全满足市场预期，尤其是利润表现不及预期，引发了投资者的担忧。
根据赛诺菲公布的财报，公司第二季度列账销售额为99.94亿欧元，同比增长6%，按固定汇率计算增长10.1%，符合市场预期。然而，撇除单次项目后的季度业务经营溢利为24.61亿欧元，低于分析师预期的25.7亿欧元。公司解释称，研发成本上升以及与合作伙伴再生元制药的更高利润分享是导致季度利润不及预期的主要原因。这一解释似乎未能完全平息市场对公司盈利能力的担忧。
尽管利润表现欠佳，赛诺菲仍上调了全年销售指引，预计销售将实现高个位数增长，高于此前预期的中至高个位数增长。公司同时确认了今年纯利将有低双位数增长的预测，但指出这一预测已计入新收购业务的所有开支。然而，这些积极信号似乎未能抵消投资者对短期利润增长的担忧，导致股价在盘中出现大幅下跌。分析人士认为，市场可能对赛诺菲的盈利能力和成本控制产生了一些疑虑，尤其是在研发支出增加的背景下。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.